These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 16698800)
1. N-terminally truncated WT1 protein with oncogenic properties overexpressed in leukemia. Hossain A; Nixon M; Kuo MT; Saunders GF J Biol Chem; 2006 Sep; 281(38):28122-30. PubMed ID: 16698800 [TBL] [Abstract][Full Text] [Related]
2. Prevalence and clinical characteristics of N-terminally truncated WT1 expression in acute myeloid leukemia. Ishikawa Y; Kiyoi H; Naoe T Leuk Res; 2011 May; 35(5):685-8. PubMed ID: 21256590 [TBL] [Abstract][Full Text] [Related]
3. Identification of a Novel C-Terminal Truncated WT1 Isoform with Antagonistic Effects against Major WT1 Isoforms. Tatsumi N; Hojo N; Sakamoto H; Inaba R; Moriguchi N; Matsuno K; Fukuda M; Matsumura A; Hayashi S; Morimoto S; Nakata J; Fujiki F; Nishida S; Nakajima H; Tsuboi A; Oka Y; Hosen N; Sugiyama H; Oji Y PLoS One; 2015; 10(6):e0130578. PubMed ID: 26090994 [TBL] [Abstract][Full Text] [Related]
4. [Inhibitory effect of WT1 gene isoform transfection on proliferation of leukemia cell line NB4]. Shen HL; Chen ZX; Wang W; Cen JN; Hu SY; Zhao Y Ai Zheng; 2006 Feb; 25(2):163-9. PubMed ID: 16480579 [TBL] [Abstract][Full Text] [Related]
5. Ribozyme-mediated cleavage of wt1 transcripts suppresses growth of leukemia cells. Hübinger G; Schmid M; Linortner S; Manegold A; Bergmann L; Maurer U Exp Hematol; 2001 Oct; 29(10):1226-35. PubMed ID: 11602325 [TBL] [Abstract][Full Text] [Related]
6. Upregulation of HOXA3 by isoform-specific Wilms tumour 1 drives chemotherapy resistance in acute myeloid leukaemia. Allen B; Savoy L; Ryabinin P; Bottomly D; Chen R; Goff B; Wang A; McWeeney SK; Zhang H Br J Haematol; 2024 Jul; 205(1):207-219. PubMed ID: 38867543 [TBL] [Abstract][Full Text] [Related]
7. Expression in Xenopus oocytes shows that WT1 binds transcripts in vivo, with a central role for zinc finger one. Ladomery M; Sommerville J; Woolner S; Slight J; Hastie N J Cell Sci; 2003 Apr; 116(Pt 8):1539-49. PubMed ID: 12640038 [TBL] [Abstract][Full Text] [Related]
8. Ubiquitin specific protease 18 (Usp18) is a WT1 transcriptional target. Shahidul Makki M; Cristy Ruteshouser E; Huff V Exp Cell Res; 2013 Mar; 319(5):612-22. PubMed ID: 23291318 [TBL] [Abstract][Full Text] [Related]
9. Wilms' tumor gene 1 protein represses the expression of the tumor suppressor interferon regulatory factor 8 in human hematopoietic progenitors and in leukemic cells. Vidovic K; Svensson E; Nilsson B; Thuresson B; Olofsson T; Lennartsson A; Gullberg U Leukemia; 2010 May; 24(5):992-1000. PubMed ID: 20237505 [TBL] [Abstract][Full Text] [Related]
10. The Wilms tumor suppressor-1 target gene podocalyxin is transcriptionally repressed by p53. Stanhope-Baker P; Kessler PM; Li W; Agarwal ML; Williams BR J Biol Chem; 2004 Aug; 279(32):33575-85. PubMed ID: 15155752 [TBL] [Abstract][Full Text] [Related]
11. Detection of a novel truncated WT1 transcript in human neoplasia. Dechsukhum C; Ware JL; Ferreira-Gonzalez A; Wilkinson DS; Garrett CT Mol Diagn; 2000 Jun; 5(2):117-28. PubMed ID: 11066013 [TBL] [Abstract][Full Text] [Related]
12. Transcriptional repression of tumor suppressor CDC73, encoding an RNA polymerase II interactor, by Wilms tumor 1 protein (WT1) promotes cell proliferation: implication for cancer therapeutics. Rather MI; Swamy S; Gopinath KS; Kumar A J Biol Chem; 2014 Jan; 289(2):968-76. PubMed ID: 24257751 [TBL] [Abstract][Full Text] [Related]
13. Cyclin A1 regulates WT1 expression in acute myeloid leukemia cells. Krug U; Yasmeen A; Beger C; Bäumer N; Dugas M; Berdel WE; Müller-Tidow C Int J Oncol; 2009 Jan; 34(1):129-36. PubMed ID: 19082485 [TBL] [Abstract][Full Text] [Related]
14. Analytical validation of a real-time reverse transcription-polymerase chain reaction quantitation of different transcripts of the Wilms' tumor suppressor gene (WT1). Dumur CI; Dechsukhum C; Wilkinson DS; Garrett CT; Ware JL; Ferreira-Gonzalez A Anal Biochem; 2002 Oct; 309(1):127-36. PubMed ID: 12381371 [TBL] [Abstract][Full Text] [Related]
15. N-terminally truncated WT1 variant (sWT1) is expressed at very low levels in acute myeloid leukemia and advanced phases of chronic myeloid leukemia. Lopotová T; Nádvorníková S; Záčková M; Polák J; Schwarz J; Klamová H; Moravcová J Leuk Res; 2012 Apr; 36(4):e81-3. PubMed ID: 22226711 [No Abstract] [Full Text] [Related]
16. Sensitivity to imatinib therapy may be predicted by testing Wilms tumor gene expression and colony growth after a short in vitro incubation. Cilloni D; Messa F; Gottardi E; Fava M; Arruga F; Defilippi I; Carturan S; Messa E; Morotti A; Giugliano E; Rege-Cambrin G; Alberti D; Baccarani M; Saglio G Cancer; 2004 Sep; 101(5):979-88. PubMed ID: 15329907 [TBL] [Abstract][Full Text] [Related]
17. The Wilms' tumor suppressor WT1 enhances CD95L expression and promotes activation-induced cell death in leukemic T cells. Bourkoula K; Englert C; Giaisi M; Köhler R; Krammer PH; Li-Weber M Int J Cancer; 2014 Jan; 134(2):291-300. PubMed ID: 23832418 [TBL] [Abstract][Full Text] [Related]
18. Presence of Wilms' tumor gene (wt1) transcripts and the WT1 nuclear protein in the majority of human acute leukemias. Menssen HD; Renkl HJ; Rodeck U; Maurer J; Notter M; Schwartz S; Reinhardt R; Thiel E Leukemia; 1995 Jun; 9(6):1060-7. PubMed ID: 7596170 [TBL] [Abstract][Full Text] [Related]
19. WT1-mediated growth suppression of Wilms tumor cells expressing a WT1 splicing variant. Haber DA; Park S; Maheswaran S; Englert C; Re GG; Hazen-Martin DJ; Sens DA; Garvin AJ Science; 1993 Dec; 262(5142):2057-9. PubMed ID: 8266105 [TBL] [Abstract][Full Text] [Related]
20. Expression of the Wilms' tumor gene WT1 in the murine urogenital system. Pelletier J; Schalling M; Buckler AJ; Rogers A; Haber DA; Housman D Genes Dev; 1991 Aug; 5(8):1345-56. PubMed ID: 1651275 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]